[Cholestasis. Recent diagnostic and therapeutic acquisitions].
New acquisitions in the field of physiopathology of biliary secretion and the improvement of methods for evaluating the biliary tree allowed a significant progress in the development of new diagnostic procedure and new therapeutical strategies for patients with cholestatic syndromes. The main novelties are here discussed.
Marucci
Luca
L
Macarri
Giampiero
G
Benedetti
Antonio
A
D002758:Cholangiography; D002760:Cholangiopancreatography, Endoscopic Retrograde; D015209:Cholangitis, Sclerosing / Q000188:drug therapy; D002769:Cholelithiasis / Q000175:diagnosis / Q000628:therapy; D002779:Cholestasis / Q000175:diagnosis* / Q000628:therapy*; D002780:Cholestasis, Intrahepatic / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000628:therapy; D002986:Clinical Trials as Topic; D016145:Endoscopy, Digestive System; D005500:Follow-Up Studies; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy / Q000401:mortality / Q000601:surgery; D016031:Liver Transplantation; D008279:Magnetic Resonance Imaging; D015201:Meta-Analysis as Topic; D009154:Mutation; D012307:Risk Factors; D013997:Time Factors; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D014580:Ursodeoxycholic Acid